Cargando…

Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators

Androgen deprivation therapy (ADT) is the mainstay regimen in patients with androgen-dependent prostate cancer (PCa). However, the selection of androgen-independent cancer cells leads to castrate resistant prostate cancer (CRPC). The aggressive phenotype of CRPC cells underscores the need to elucida...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mondal, Debasis, Narwani, Devin, Notta, Shahnawaz, Ghaffar, Dawood, Mardhekar, Nikhil, Quadri, Syed S. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019181/ https://www.ncbi.nlm.nih.gov/pubmed/35582006 http://dx.doi.org/10.20517/cdr.2020.71

Ejemplares similares

Systematically understanding the immunity leading to CRPC progression
por: Ji, Zhiwei, et al.
Publicado: (2019)

The Nrf1 and Nrf2 Balance in Oxidative Stress Regulation and Androgen Signaling in Prostate Cancer Cells
por: Schultz, Michelle A., et al.
Publicado: (2010)

Estradiol-ERβ2 signaling axis confers growth and migration of CRPC cells through TMPRSS2-ETV5 gene fusion
por: Kim, Hogyoung, et al.
Publicado: (2016)

The Pathological Role of Pro(Renin) Receptor in Renal Inflammation
por: Quadri, Syed S, et al.
Publicado: (2021)

A Case of Hand-Foot-and-Mouth Disease in an Adult Male
por: Jagadish, Ashwin, et al.
Publicado: (2023)

Molecular Interplay between AURKA and SPOP Dictates CRPC Pathogenesis via Androgen Receptor
por: Nikhil, Kumar, et al.
Publicado: (2020)

Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC
por: Zhang, Yaqun, et al.
Publicado: (2019)

Comprehensive analysis of the progression mechanisms of CRPC and its inhibitor discovery based on machine learning algorithms
por: Wang, Zhen, et al.
Publicado: (2023)

Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
por: Chandrasekar, Thenappan, et al.
Publicado: (2015)

Emerging Proteins in CRPC: Functional Roles and Clinical Implications
por: Kong, Piaoping, et al.
Publicado: (2022)

Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC
por: White, Ralph E., et al.
Publicado: (2023)

Progressive Rotavirus Infection Downregulates Redox-Sensitive Transcription Factor Nrf2 and Nrf2-Driven Transcription Units
por: Patra, Upayan, et al.
Publicado: (2020)

Cardiorenal Disease in COVID-19 Patients
por: Sifaat, Muhtasham, et al.
Publicado: (2022)

Amplification of MUC1 in prostate cancer metastasis and CRPC development
por: Wong, Nicholas, et al.
Publicado: (2016)

Immune checkpoint inhibitors in mCRPC - rationales, challenges and perspectives
por: Taghizadeh, H., et al.
Publicado: (2019)

Radium-223 Treatment in mCRPC Patient with Polycythemia Vera
por: de Angelis, Cristina, et al.
Publicado: (2021)

Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC
por: Rosar, Florian, et al.
Publicado: (2022)

Nrf2 mediates redox adaptations to exercise
por: Done, Aaron J., et al.
Publicado: (2016)

A Case of Ceftaroline-Associated Thrombocytopenia
por: Jagadish, Ashwin, et al.
Publicado: (2023)

Nrf1 and Nrf2 Transcription Factors Regulate Androgen Receptor Transactivation in Prostate Cancer Cells
por: Schultz, Michelle A., et al.
Publicado: (2014)

Clinical aspects of mCRPC management in patients treated with radium-223
por: Rizzini, Elisa Lodi, et al.
Publicado: (2020)

Tousled-like kinase 1: a novel factor with multifaceted role in mCRPC progression and development of therapy resistance
por: Khalil, Md Imtiaz, et al.
Publicado: (2022)

Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer
por: Kang, Ning, et al.
Publicado: (2023)

Nrf2 and Redox Status in Prediabetic and Diabetic Patients
por: Jiménez-Osorio, Angélica S., et al.
Publicado: (2014)

The role of Nrf1 and Nrf2 in the regulation of glutathione and redox dynamics in the developing zebrafish embryo
por: Sant, Karilyn E., et al.
Publicado: (2017)

Impact of Age at Diagnosis on Outcomes in Men with Castrate-Resistant Prostate Cancer (CRPC)
por: Humphreys, Michael R, et al.
Publicado: (2013)

Changing paradigms in management of metastatic Castration Resistant Prostate Cancer (mCRPC)
por: Gupta, Eva, et al.
Publicado: (2014)

Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
por: Fan, Lilv, et al.
Publicado: (2021)

Current and Emerging Therapies for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
por: Henríquez, Iván, et al.
Publicado: (2021)

An ensemble-based Cox proportional hazards regression framework for predicting survival in metastatic castration-resistant prostate cancer (mCRPC) patients
por: Meier, Richard, et al.
Publicado: (2016)

Vitamin D Deficiency and Tuberculosis Progression
por: Talat, Najeeha, et al.
Publicado: (2010)

NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
por: Carpenter, Evan L., et al.
Publicado: (2022)

Redox Regulation of Nrf2 in Cisplatin-Induced Kidney Injury
por: Mapuskar, Kranti A., et al.
Publicado: (2023)

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison
por: Tan, Pui S, et al.
Publicado: (2014)

Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study
por: Delanoy, Nicolas, et al.
Publicado: (2021)

Oxidative Stress in Cardiovascular Diseases: Involvement of Nrf2 Antioxidant Redox Signaling in Macrophage Foam Cells Formation
por: Ooi, Bee Kee, et al.
Publicado: (2017)

Targeted alpha therapy of mCRPC: Dosimetry estimate of (213)Bismuth-PSMA-617
por: Kratochwil, Clemens, et al.
Publicado: (2017)

SUN-003 Targeting Androgen Receptor-CXCR7-MARK Signaling Axis in CRPC
por: Gritsina, Galina, et al.
Publicado: (2019)

PROpel trial: Are PARP inhibitors ready to become the first-line treatment for mCRPC?
por: Gaur, Abhay Singh
Publicado: (2022)

Two cases of CRPC with BRCA mutation treated by olaparib after favorable response to cisplatin
por: Miyazawa, Yoshiyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r4fuqnvfsgiggq3nvd0gf6pj9g